Let M3 Global Research expand your world. Learn why M3 Global Research is the obvious choice for your quantitative and qualitative market research needs.
Let M3 Global Research expand your world. Learn why M3 Global Research is the obvious choice for your quantitative and qualitative market research needs.
Watch this video to learn why M3 Global Research has the best panel for your research projects.
Learn more about M3 Global Research's experience and capabilities in our "at a glance" overview.
M3 Global Research offers a targeted metastatic breast cancer patient community, specifically focused on HR+, HER2-, available for your upcoming research projects. Read this data sheet to learn more.
This webinar discusses today’s increasingly compliance-driven and cost-sensitive pharmaceutical environment and the possibility for business intelligence professionals to deliver quick insights to their internal teams within 48-hours. M3 explores agile research, its collaborative approach and its important application within insights and business intelligence; including the challenges faced and options to help overcome them.
This paper walks you through the recruitment methodologies M3 Global Research uses for patient recruitment, timelines, patient sensitivities to be mindful of, and the key things to note about partnership relationship building.
Most blood cancers, also called hematologic cancers, start in the bone marrow, which is the spongy tissue inside the bones where blood cells are made. Over 900,000 people worldwide are diagnosed with blood cancer every year. Learn more about blood cancers in this therapeutic review.
China has established a well-developed healthcare system that provides infectious disease control, emergency care, outpatient services, and inpatient services. Every city and county also has at least one traditional Chinese medicine (TCM) hospital, and most medical institutions and health facilities have a TCM department. Learn more about China's healthcare system to help you prepare for your upcoming studies in China.
Do you have a qualitative study coming up? M3 Global Research has the extensive experience required to make your study a success. Learn more about M3's qualitative capabilities in this infographic.
This webinar focuses on M3's unique approach to recruiting and managing qualitative market research projects. Combining technology with a personal touch yields quality research results. M3 presents its distinctive way to recruit respondents for different qualitative methodologies and provides an inside look at the proprietary system that delivers unprecedentedly fast results.
Brasil's Sistema Único de Saúde (SUS) has been widely recognized as an example of successful healthcare reform in Latin America. Improvements to the management of the universal system and the expansion of primary healthcare have contributed to expanded coverage and access and improved patient outcomes. Read our country profile to learn more about conducting research in Brasil.
M3 Global Research's client was seeking to interview Non-Alcoholic SteatoHepatitis (NASH) patients with stage F3 and F4 fibrosis to understand their individual journey related to living with the disease. Problem was, there is not a large population of 'identified' NASH patients.
While the sun offers many benefits, such as vitamin D and improvements in mood, we all know there are reasons to defend ourselves from its harmful rays. Read these tips to learn how to protect yourself from UV radiation.
Learn about an interactive, qualitative approach to market research that assembles people virtually to facilitate data collection and produces in-depth insights similar to that of an in-person focus group. This methodology allows researchers to gather opinions from participants across a wide geographic area or with varying levels of availability regardless of their time zone or work schedules.
Quality goes hand-in-hand with compliance, and obtaining quality without compliance would be quite a challenge. Read this paper to learn about the various rules that businesses like M3 Global Research must follow to ensure both quality and compliance.
This webinar focuses on recruiting patient targets for market research (MR) studies. M3 Global Research has unique custom recruitment solutions and this webinar walks you through everything from selecting a methodology and understanding feasibility and timelines to respondent sensitivities and out-of-the-box recruitment methods. You will learn how to make an impact with your research findings, solve business issues, and ultimately have the patients’ voices heard.
M3 Global Research panel members in the UK shared their opinion on the accessibility of cannabis-based products for medical use. Results revealed that the vast majority of patients are ready for the rules to relax and for the NHS to cover the costs.
The country of Sweden has a long tradition of delivering high quality, economically viable healthcare. Over the past 20 years, Sweden has an average reinvestment of 9.2 percent of its GDP annually on healthcare. However, around 70 percent of healthcare services are funded through local government taxes. Learn more about Sweden’s healthcare system in this country profile.
This webinar focuses on the benefits of market research with QQFS. Our QQFS team has 20 years of experience conducting healthcare fieldwork in the Nordics, Benelux and the Alpines and they share key learnings, including the unique challenges presented in these regions. The team also shares how being part of a leading healthcare technology company strengthens their business and benefits their customers.
Client lists can seem like the perfect resource for medical market research studies but if you want to maximise your return, you'll need to understand the factors that impact feasibility, how your fieldwork agency can best help you, plus learn recruitment tactics that really work.
Have a study coming up in Sweden? M3 Global Research is the partner you need. Learn about our unique capabilities in Sweden in this infographic.
This webinar goes through ISO 26362’s influence throughout a project lifecycle and provides real-life examples of how it has helped to improve and maintain quality.
Colorectal cancer (CRC) is a cancer that starts in the colon or the rectum. Learn about the disease, who is at risk, and how it is treated in this therapeutic review.
Real World Research delivers in-depth clinical understanding of multiple therapy areas by capturing data from not just the treating physician but also the patient themselves. Read our data sheet to learn about M3 Global Research’s capabilities in this area of market research.
The 2018 year was a productive one for M3 Global Research. Learn more by viewing our 2018 Review infographic.
Have a study coming up in China? M3 Global Research is the partner you need. Learn about our unique capabilities in China in this infographic.
As the M3 Global Research unique research highlights, respondents themselves know how and why their interest wanes. So, addressing these challenges through gamified approaches will improve engagement and, more importantly, the quality of captured data.
Acquired immunodeficiency syndrome (AIDS) is the progression in severity of untreated or undertreated human immunodeficiency virus (HIV) infections. Read our therapeutic review about aids to learn more.
Diabetes mellitus is a metabolically complex, chronic, and progressive disease. Read our therapeutic review about diabetes to learn more.
This case study examines an M3 Global Research project for an end-client who wanted to understand the prevalence of certain treatments utilized by oncologists treating a rare disease. Read the case study to learn how M3 overcame some unique challenges to deliver a successful project outcome.
Have a study coming up in Japan? M3 Global Research is the partner you need. Learn about our unique capabilities in Japan in this infographic.
As the pharma industry embraces patient-centricity, one of the hottest topics emerging in the market research industry is the increasing demand for longitudinal patient studies and bespoke community builds.
Find out more about M3 Patient Access, a new patient engagement project designed to meet the changing needs of healthcare market research.
In observance of anti-bullying month in the US and anti-bullying week in the UK, M3 Global Research seeks to raise awareness of the endemic issue of bullying in hospitals and healthcare facilities.
Breast cancer is the most common cancer in women, and one of the most common cancers diagnosed overall. Read our therapeutic review about breast cancer to learn more.
This paper explores some of the more continuous and challenging elements of GDPR as it relates to the market research industry.
Chronic pain is one of the most common conditions for patients seeking medical attention and opioids, often prescribed for chronic pain, are some of the most commonly abused drugs worldwide. Read our therapeutic review about chronic pain and opioid abuse to learn more.
Read this document to learn about M3 Global Research’s Loi Anti-Cadeaux and Bertrand Act Processes.
It is vital to be prepared with a good sampling plan and always keep project objectives in the forefront. Read this paper to learn about the best practices for getting your market research sample right.
The United Kingdom (UK) is a sovereign state located off the north-western coast of Europe, made up of four nations: England, Wales, Scotland, and Northern Ireland. Healthcare in the UK is handled at a subnational level with England, Northern Ireland, Scotland, and Wales each having their own systems of publicly-funded healthcare. Learn more by reading our United Kingdom Country Profile.
Hepatitis is a condition resulting from inflammation of the liver cells and damage to the liver. There are different types and causes, but the symptoms can be similar. Read our Therapeutic Review to learn more about hepatitis.
Psoriasis is a non-communicable, chronic disease caused by an overactive immune system attacking the body’s skin cells. Learn more about psoriasis by reading our therapeutic review data sheet.
Working for a full-service market research company working with a clinical-stage biotechnology company focused on development of therapeutic antibodies for improvement in cancer treatment, M3 Global Research was seeking to secure “payers” to participate in the research focused on Cutaneous T Cell Lymphoma (CTCL). Learn more by reading this case study.
There remain some important unanswered questions for the market research industry following the introduction of GDPR. Quality and compliance are fundamental to the M3 Global Research approach, and many clients have asked us to share our viewpoint on these important topics.
Haemophilia is a bleeding disorder in which clotting factor defi ciencies lead to bleeding in various areas of the body, with the most common types of bleeds being into the joints and muscles. Learn more about Haemophilia by reading our latest therapeutic review sheet.
The population of France has experienced marginal year-over-year growth for decades, while wealth has risen, leading to a highly developed country with a stable population model. Learn about France's healthcare in this country profile.
Data quality is of the utmost importance at M3 Global Research. To ensure the best possible quality, M3 uses a three-step-verification process before, during, and after a market research study. Read our Verification Overview to learn more.
At M3 Global Research, we take data protection seriously. The General Data Protection Regulation is now in effect, and we’ve got it covered. Here are just some of the things we are doing to keep your data safe.
General Data Protection Regulation (GDPR) will go into effect on 25 May, 2018 across the European Union. We’ve assembled this checklist to help you prepare.
General Data Protection Regulation (GDPR) will go into effect on 25 May, 2018 across the European Union.
Over the last twenty years, Japan’s healthcare spending has been on the rise and this trend is expected to continue. A fast-growing, aging population and increasing cases of chronic diseases make Japan a long-term growth market for pharmaceutical companies. Between 2014 and 2018, healthcare spending is expected to rise by an average of three percent a year, reaching around 10 percent of GDP by the end of 2018.
Check our 2017 M3 review by the numbers.
M3 Global Research client Deerfield Institute has had a paper on ovarian cancer published by Dove Medical Press, which details how M3 Global Research was used in Europe to contact medical and gynecologic oncologists.
M3 is active in recruiting for our client’s studies in the ophthalmology disease area. In 2016, we recruited over 13,000 respondents across 35 countries, for almost 100 studies and >50 clients. Most (68) were online quantitative surveys, 17 were qualitative only projects, and 11 included both study type activities.
M3 is active in recruiting for our client’s studies in the pulmonary and pediatric disease area. In 2016, we recruited over 14,000 respondents for >220 studies with >150 clients across 67 countries. Most (143) were online quantitative surveys, 63 were qualitative only projects, and 16 included both study type activities. Cystic Fibrosis was the primary topic area in 9 studies among >725 respondents in 12 countries.
Irritable Bowel Syndrome (IBS) is a complex, poorly understood condition which is estimated to affect up to 15% of the US population. The condition primarily affects women, but up to 25% of the ~30 million sufferers are men. IBS is frequently divided into three segments depending on the patients symptoms: IBS-C (constipation dominant), IBS-D (diarrhea dominant), and IBS-mixed (both constipation and diarrhea).
In 2016, nearly 5,000 physicians who treat renal disease participated in 78 research studies across 14 countries with M3. Most (45) were online quantitative surveys, 27 were qualitative only projects, and 8 were for both study type activities.
Check our 2016 M3 review by the numbers.
M3 is active in recruiting for our client’s studies in the Cardiology space. In 2015, we recruited almost 21,000 healthcare professionals for over 230 studies across 20 or more countries. Surveys were completed primarily among hospital and nonhospital- based physicians in the Cardiologists / Cardiac Surgeons and Primary Care specialties.
M3 is active in recruiting for our client’s studies addressing the myriad issues and disease areas seen by Endocrinologists. In 2015 M3 studies alone, endocrinologists completed over 1,000 surveys across 50 plus studies and 24 countries.
At M3 we diligently answer ESOMAR 28 questions to ensure your project is carried out meeting your quality requirements for online samples.
Our client was interested in helping their Pharma client gauge insight and reaction ‘in the moment’ to five specific abstracts or oral sessions, and conducting immediate response research with attendees soon after specific sessions ended.
M3 built on its extensive experience recruiting oncologists worldwide and expanded into a related audience in the community. The combined effort across US and EU M3 offices with local partners resulted in the successful recruitment of 50 leaders of patient advocacy groups across 28 countries.
With over 12 years' experience in the industry, M3 is the US leader among digitally active specialty HCPs and is the owner/operator of leading award winning HCP brands. M3 is actively engaged with 14 of the top 15 pharma companies & provides extensive coverage of EU20 physicians.
Inching Toward Hospital Ownership, offers four viewpoints on the practice arrangements of physicians in 2014, and the practice changes that have taken place between 2012 and 2014.
A detailed Look at the Methods Used to Compensate Physicians in Different Practice Types and Specialties, provides a detailed look at how physicians are paid by their practices.